SonoScape Medical Corp Stock Shenzhen S.E.
Stocks
Advanced Medical Equipment & Technology
|
End-of-day quote
Shenzhen S.E.
|
||
| - CNY | - |
|
| Market Cap | 1.22B 8.2B 1.08B 1.02B 921M 1.74B 117B 1.76B 12.21B 4.7B 59.95B 4.59B 4.49B 192B | P/E 2026 * |
29.7x | P/E 2027 * | 21.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1.05B 7.06B 926M 878M 792M 1.49B 101B 1.51B 10.5B 4.04B 51.56B 3.95B 3.86B 165B | EV / Sales 2026 * |
2.71x | EV / Sales 2027 * | 2.27x |
| Free-Float |
43.66% | Yield 2026 * |
1.17% | Yield 2027 * | 2.02% |
| Manager | Title | Age | Since |
|---|---|---|---|
Kun Xiang Wu
CEO | Chief Executive Officer | 63 | 2014-12-21 |
Yue Zuo Luo
DFI | Director of Finance/CFO | 43 | 2014-12-21 |
Nai Zhang Feng
PRN | Corporate Officer/Principal | 51 | 2024-07-25 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhi Qiang Chen
CHM | Chairman | 61 | 2014-12-21 |
Kun Xiang Wu
BRD | Director/Board Member | 63 | 2002-09-26 |
Yi Bo Huang
BRD | Director/Board Member | 60 | 2001-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.67% | +1.47% | +39.18% | +33.36% | 250B | |
| -2.02% | -0.00% | +11.75% | -10.70% | 156B | |
| -1.35% | +2.09% | -9.08% | +39.12% | 144B | |
| -0.52% | -2.17% | -55.29% | -17.33% | 63.26B | |
| -2.00% | -0.58% | +10.99% | +24.60% | 49.75B | |
| -1.55% | +4.23% | +34.25% | +54.10% | 48.58B | |
| -0.75% | +1.21% | -18.66% | -21.66% | 47.99B | |
| +2.47% | +5.43% | -4.18% | +40.30% | 46.22B | |
| -0.87% | +4.47% | +46.56% | +60.24% | 43.17B | |
| Average | -0.59% | +2.27% | +6.17% | +22.45% | 94.22B | |
| Weighted average by Cap. | -0.67% | +2.37% | +11.72% | +21.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 389M 2.61B 342M 324M 293M 552M 37.28B 559M 3.88B 1.49B 19.06B 1.46B 1.43B 61.1B | 442M 2.97B 390M 369M 333M 628M 42.42B 636M 4.42B 1.7B 21.69B 1.66B 1.63B 69.53B |
| Net income | 41.38M 278M 36.44M 34.53M 31.17M 58.75M 3.97B 59.51M 413M 159M 2.03B 155M 152M 6.5B | 56.86M 381M 50.07M 47.44M 42.83M 80.72M 5.45B 81.76M 568M 218M 2.79B 214M 209M 8.94B |
| Net Debt | -171M -1.15B -151M -143M -129M -243M -16.4B -246M -1.71B -657M -8.39B -642M -628M -26.88B | -220M -1.48B -194M -184M -166M -312M -21.09B -316M -2.2B -845M -10.78B -826M -808M -34.56B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
